OptimizeRx Corporation Statistics
Share Statistics
OptimizeRx Corporation has 18.42M shares outstanding. The number of shares has increased by 1.48% in one year.
| Shares Outstanding | 18.42M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.54% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 15.73M |
| Failed to Deliver (FTD) Shares | 51 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 1.10M, so 5.96% of the outstanding shares have been sold short.
| Short Interest | 1.10M |
| Short % of Shares Out | 5.96% |
| Short % of Float | 6.89% |
| Short Ratio (days to cover) | 2.45 |
Valuation Ratios
The PE ratio is -13.95 and the forward PE ratio is 11.92.
| PE Ratio | -13.95 |
| Forward PE | 11.92 |
| PS Ratio | 3.43 |
| Forward PS | 0.8 |
| PB Ratio | 1.94 |
| P/FCF Ratio | -30.21 |
| PEG Ratio | n/a |
Enterprise Valuation
OptimizeRx Corporation has an Enterprise Value (EV) of 268.03M.
| EV / Earnings | -15.26 |
| EV / Sales | 3.75 |
| EV / EBITDA | -12.58 |
| EV / EBIT | -10.15 |
| EV / FCF | -33.05 |
Financial Position
The company has a current ratio of 3.04, with a Debt / Equity ratio of 0.29.
| Current Ratio | 3.04 |
| Quick Ratio | 3.04 |
| Debt / Equity | 0.29 |
| Total Debt / Capitalization | 22.26 |
| Cash Flow / Debt | -0.2 |
| Interest Coverage | -18.16 |
Financial Efficiency
Return on equity (ROE) is -0.14% and return on capital (ROIC) is -11.28%.
| Return on Equity (ROE) | -0.14% |
| Return on Assets (ROA) | -0.1% |
| Return on Capital (ROIC) | -11.28% |
| Revenue Per Employee | 529.79K |
| Profits Per Employee | -130.12K |
| Employee Count | 135 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | -7.60M |
| Effective Tax Rate | 0.3 |
Stock Price Statistics
The stock price has increased by -67.34% in the last 52 weeks. The beta is 1.32, so OptimizeRx Corporation's price volatility has been higher than the market average.
| Beta | 1.32 |
| 52-Week Price Change | -67.34% |
| 50-Day Moving Average | 5.15 |
| 200-Day Moving Average | 8.37 |
| Relative Strength Index (RSI) | 44.51 |
| Average Volume (20 Days) | 308.26K |
Income Statement
In the last 12 months, OptimizeRx Corporation had revenue of 71.52M and earned -17.57M in profits. Earnings per share was -1.03.
| Revenue | 71.52M |
| Gross Profit | 42.90M |
| Operating Income | -26.40M |
| Net Income | -17.57M |
| EBITDA | -21.31M |
| EBIT | -26.40M |
| Earnings Per Share (EPS) | -1.03 |
Balance Sheet
The company has 13.85M in cash and 36.82M in debt, giving a net cash position of -22.97M.
| Cash & Cash Equivalents | 13.85M |
| Total Debt | 36.82M |
| Net Cash | -22.97M |
| Retained Earnings | -64.26M |
| Total Assets | 165.20M |
| Working Capital | 32.40M |
Cash Flow
In the last 12 months, operating cash flow was -7.24M and capital expenditures -871.42K, giving a free cash flow of -8.11M.
| Operating Cash Flow | -7.24M |
| Capital Expenditures | -871.42K |
| Free Cash Flow | -8.11M |
| FCF Per Share | -0.47 |
Margins
Gross margin is 59.98%, with operating and profit margins of -36.91% and -24.56%.
| Gross Margin | 59.98% |
| Operating Margin | -36.91% |
| Pretax Margin | -35.18% |
| Profit Margin | -24.56% |
| EBITDA Margin | -29.79% |
| EBIT Margin | -36.91% |
| FCF Margin | -11.34% |
Dividends & Yields
OPRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -21.19% |
| FCF Yield | -9.06% |
Analyst Forecast
The average price target for OPRX is $8, which is 64.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $8 |
| Price Target Difference | 64.6% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
Stock Splits
The last stock split was on May 14, 2018. It was a backward split with a ratio of 1:3.
| Last Split Date | May 14, 2018 |
| Split Type | backward |
| Split Ratio | 1:3 |
Scores
| Altman Z-Score | 0.72 |
| Piotroski F-Score | 3 |